Major Investor Group Reduces Stake in KORU Medical Systems by 1.69%
KRMD has more than doubled off its 52-week low of $1.86.
Summary
Horton Capital Partners and Joseph M. Manko, Jr. have reduced their aggregate beneficial ownership in KORU Medical Systems, Inc. by 782,547 shares, representing a 1.69% decrease in their stake, primarily through in-kind distributions to limited partners.
Key Events · Ownership and Investor Activity · KRMD
-
Significant Stake Reduction
Horton Capital Partners and Joseph M. Manko, Jr. reduced their aggregate beneficial ownership by 782,547 shares, decreasing their stake from 14.31% to 12.62%.
-
In-Kind Distributions
The reduction was primarily due to in-kind distributions of shares from Horton Capital Partners Fund, LP to its limited partners, and subsequently to its members, including Joseph M. Manko, Jr.
-
Director's Involvement
Joseph M. Manko, Jr., a director of KORU Medical Systems, is part of the reporting group that reduced its overall beneficial ownership.
Analysis · KRMD · Industrial Applications And Services
This Schedule 13D/A reports a significant reduction in the beneficial ownership of KORU Medical Systems by Horton Capital Partners and its managing member, Joseph M. Manko, Jr., who also serves as a director. The group's aggregate stake decreased by 782,547 shares, or 1.69% of the company's outstanding common stock, since their last filing. This reduction, valued at approximately $3.65 million based on today's stock price, primarily stems from in-kind distributions of shares from the fund to its limited partners. While these are not open market sales, the decrease in a major investor group's overall position, which includes a director, could be interpreted as a slight negative signal regarding their long-term conviction or a strategic rebalancing of their portfolio. Investors should monitor future filings for any further changes in this group's ownership.
How filings like this one have moved
In the 30 days to Sep 16, 2026, 29.6% of the 1725 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.33%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KRMD was trading at $4.67 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $216.3M. The 52-week trading range was $1.86 to $6.61. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.